Literature DB >> 20352528

The iPS technique provides hope for Parkinson's disease treatment.

Liang Xu1, Yu-Yan Tan, Jian-Qing Ding, Sheng-Di Chen.   

Abstract

More recently, reprogramming of somatic cells to an embryonic stem cell-like state presents a milestone in the realm of stem cells, making it possible to derive all cell types from any patients bearing specific genetic mutations. With the development of induced pluripotent stem (iPS) cells, we are now able to use the derivatives of iPS cells to study the mechanisms of disease and to perform drug screening and toxicology testing. In addition, differentiated iPS cells are now close to be used in clinical practice. Here we review the progress of iPS technique and the possible application in the area of Parkinson's disease treatment.

Entities:  

Mesh：

Year:  2010        PMID： 20352528     DOI： 10.1007/s12015-010-9145-2

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN： 2629-3277            Impact factor:   5.739


  58 in total

1.  Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells.

Authors:  S H Lee; N Lumelsky; L Studer; J M Auerbach; R D McKay
Journal:  Nat Biotechnol       Date:  2000-06       Impact factor: 54.908

Review 2.  Guidelines and techniques for the generation of induced pluripotent stem cells.

Authors:  Nimet Maherali; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2008-12-04       Impact factor: 24.633

3.  Defined, feeder-independent medium for human embryonic stem cell culture.

Authors:  Tenneille Ludwig; James A Thomson
Journal:  Curr Protoc Stem Cell Biol       Date:  2007-09

4.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

5.  A high-efficiency system for the generation and study of human induced pluripotent stem cells.

Authors:  Nimet Maherali; Tim Ahfeldt; Alessandra Rigamonti; Jochen Utikal; Chad Cowan; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

6.  Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.

Authors:  Chunliang Li; Junmei Zhou; Guilai Shi; Yu Ma; Ying Yang; Junjie Gu; Hongyao Yu; Shibo Jin; Zhe Wei; Fang Chen; Ying Jin
Journal:  Hum Mol Genet       Date:  2009-08-13       Impact factor: 6.150

7.  iPS cells produce viable mice through tetraploid complementation.

Authors:  Xiao-yang Zhao; Wei Li; Zhuo Lv; Lei Liu; Man Tong; Tang Hai; Jie Hao; Chang-long Guo; Qing-wen Ma; Liu Wang; Fanyi Zeng; Qi Zhou
Journal:  Nature       Date:  2009-09-03       Impact factor: 49.962

Review 8.  Strategies and new developments in the generation of patient-specific pluripotent stem cells.

Authors:  Shinya Yamanaka
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

9.  Human adult marrow cells support prolonged expansion of human embryonic stem cells in culture.

Authors:  Linzhao Cheng; Holly Hammond; Zhaohui Ye; Xiangcan Zhan; Gautam Dravid
Journal:  Stem Cells       Date:  2003       Impact factor: 6.277

10.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908
View more
  6 in total

Review 1.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  Tracking stem cell differentiation in the setting of automated optogenetic stimulation.

Authors:  Albrecht Stroh; Hsing-Chen Tsai; Li-Ping Wang; Feng Zhang; Jenny Kressel; Alexander Aravanis; Nandhini Santhanam; Karl Deisseroth; Arthur Konnerth; M Bret Schneider
Journal:  Stem Cells       Date:  2011-01       Impact factor: 6.277

Review 3.  Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases.

Authors:  Lei Cao; Lan Tan; Teng Jiang; Xi-Chen Zhu; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2014-08-23       Impact factor: 5.590

4.  Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis.

Authors:  Iuliana Ristea Popescu; Charles Nicaise; Song Liu; Grégoire Bisch; Sarah Knippenberg; Valery Daubie; Delphine Bohl; Roland Pochet
Journal:  Stem Cells Transl Med       Date:  2013-02-14       Impact factor: 6.940

5.  Comparative neuronal differentiation of self-renewing neural progenitor cell lines obtained from human induced pluripotent stem cells.

Authors:  Chiara Verpelli; Luigi Carlessi; Giulia Bechi; Elena Fusar Poli; Daniel Orellana; Christopher Heise; Silvana Franceschetti; Renato Mantegazza; Massimo Mantegazza; Domenico Delia; Carlo Sala
Journal:  Front Cell Neurosci       Date:  2013-10-07       Impact factor: 5.505

Review 6.  Progress on stem cell research towards the treatment of Parkinson's disease.

Authors:  Stuart A J Gibson; Guo-Dong Gao; Katya McDonagh; Sanbing Shen
Journal:  Stem Cell Res Ther       Date:  2012-04-03       Impact factor: 6.832
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.